Finding inspiration in opioid-induced respiratory depression.
Finding inspiration in opioid-induced respiratory depression.
复制标题
在阿片类药物引起的呼吸抑制中寻找灵感。
DOI:
10.1113/jp279083
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Szujewski,CarolineC
中科院分区:
文献类型:
--
作者:
Garcia3rd,AlfredoJ;Szujewski,CarolineC
Opioids are a class of psychoactive drugs that serve like a double-edged sword. While effective analgesic agents, the highly addictive nature of these substances enhances the likelihood for abuse. In The United States alone, nearly 1.7 million people suffer from substance use disorders related to prescription opioids and therefore, at an increased risk for opioid overdose. Despite this risk, far less progress has been made towards understanding the physiological basis for the hallmark of opioid overdose, respiratory depression, as compared to the physiology underlying opioid based analgesia and addiction.While it is well-accepted that opioids act centrally through mu opioid receptors (MORs) to cause respiratory depression, these receptors are widely distributed throughout neural networks largely responsible for the central control of breathing. For example, MORs are expressed in both the preBötzinger complex, the putative site of inspiratory rhythmogenesis (Smith et al., 1991), and the Kölliker-Fuse nucleus, a key network involved with regulating the eupneic pattern (St-John & Paton, 2004). The synaptic interconnectivity throughout the respiratory network creates a significant problem for delineating the individual role of these two areas in opioid related respiratory depression. In this issue of The Journal of Physiology, Levitt and colleagues—including Adrienn Varga as first author—reveal a significant dosedependent distinction in the role for the Kolliker-Fuse nucleus and the preBötzinger complex leading to respiratory depression (Varga et al., 2019).